<DOC>
	<DOCNO>NCT00631657</DOCNO>
	<brief_summary>To investigate long-term efficacy safety treatment esmirtazapine ( Org 50081 , SCH 900265 , MK-8265 ) compare placebo , participant chronic primary insomnia . Primary efficacy variable Total Sleep Time ( TST ) .</brief_summary>
	<brief_title>A 6-Month Efficacy Safety Study Org 50081 Adult Patients With Chronic Primary Insomnia ( 21106/P05701/MK-8265-002 )</brief_title>
	<detailed_description>Insomnia common complaint disorder throughout world . About one third population industrial country report difficulty initiate maintain sleep , result non-refreshing non-restorative sleep . The majority insomniac suffer chronically complaint . The maleic acid salt Org 4420 , code name Org 50081 ( esmirtazapine ) , select development treatment insomnia . The first clinical trial esmirtazapine proof-of-concept trial four-way cross-over design . All 3 esmirtazapine dose group show statistically significant positive effect TST ( objective subjective ) Wake Time After Sleep Onset ( WASO ) , compare placebo . The current study design assess long-term efficacy safety esmirtazapine double-blind , randomize , placebo-controlled , parallel group outpatient trial participant suffer chronic primary insomnia . During 6-month treatment period , participant randomly assign receive either esmirtazapine placebo . Then , 7-day discontinuation period , participant receive esmirtazapine 6-month treatment period randomly assign receive either esmirtazapine placebo , participant receive placebo 6-month treatment period continue receive placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Disorders , Intrinsic</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<criteria>least 18 less 65 year ; sign write informed consent scope nature investigation explain ; show capability complete LogPad questionnaire ; difficulty fall asleep , maintain sleep early morning awakening ; Significant medical psychiatric illness cause sleep disturbance . Have history bipolar disorder attempt suicide family ( immediate family ) history suicide . Have sleep disorder sleeprelated breathe disorder , restless leg syndrome , narcolepsy . Significant medical illness acute chronic pain , heart , kidney , liver disease within last year . Currently diagnose meet criterion Major Depressive Disorder ( MDD ) treat MDD last 2 year . Substance abuse , excessive use alcohol ( determined physician ) drug addiction within last year . Are night worker rotate shift worker plan travel 3 timezones . Routinely nap day . Have Body Mass Index ( BMI ) 36 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>placebo control</keyword>
	<keyword>randomize</keyword>
	<keyword>double blind</keyword>
</DOC>